GP2U Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Employees
-
12
- Latest Deal Type
-
M&A
- (Announced)
- Latest Deal Amount
-
$1.99M
- Investors
-
1
GP2U General Information
Description
Provider of diagnosis, immediate prescriptions, specialist referrals, and medical certificates intended from the comfort and convenience of home or the office. The company offers secure video-based consultations and is integrated into the Australian healthcare system, enabling patients to get prescriptions, pathology requests, specialist referrals, and secure messaging.
Contact Information
Website
www.gp2u.com.au(Operating Subsidiary)
Corporate Office
- Level 2, 38 Montpelier Reteat
- Battery Point
- Hobart, Tasmania 7004
- Australia
Corporate Office
- Level 2, 38 Montpelier Reteat
- Battery Point
- Hobart, Tasmania 7004
- Australia
GP2U Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 04-Jun-2023 | $1.99M | 00.000 | Announced | Generating Revenue | |
3. Merger/Acquisition | 09-Sep-2021 | 0000 | 00.00 | 0000 | Completed | Generating Revenue |
2. Early Stage VC | 23-Dec-2015 | $2.2M | $3.2M | Completed | Generating Revenue | |
1. Seed Round | 01-Jan-2015 | $1M | $1M | Completed | Generating Revenue |
GP2U Comparisons
Industry
Financing
Details
GP2U Competitors (5)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eucalyptus | Venture Capital-Backed | Sydney, Australia | 000 | 000.00 | 0000000000 0 | 000.00 |
Koa Health | Venture Capital-Backed | London, United Kingdom | 00 | 000.00 | 000000 0 | 000.00 |
Medifi | Venture Capital-Backed | San Francisco, CA | 0 | 00.000 | 000000000 | 00.000 |
Doxy.me | Corporation | Rochester, NY | 000 | 0000000000 | ||
Healee | Venture Capital-Backed | Sofia, Bulgaria | 00 | 00.000 | 000000000000 | 00.000 |
GP2U Executive Team (5)
Name | Title | Board Seat |
---|---|---|
James Freeman | Founder & Executive Director | |
Maxwell Conway | Finance Manager |
GP2U Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Amit Vohra Ph.D | Self | Chairman | 000 0000 |
Andrew Pascoe | Self | Board Member | 000 0000 |
John McDonald | Self | Board Member | 000 0000 |
Julie Andrews | Self | Board Member | 000 0000 |
GP2U Signals
GP2U Former Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Andrew Pascoe | Angel (individual) | Minority | 000 0000 | 000000 0 |
Hospitals Contribution Fund of Australia | Corporation | Minority | 000 0000 | 000000 0 |
Max Reed | Angel (individual) | Minority | 000 0000 | 000000 0 |
Sonic Healthcare | Corporation | Minority | 000 0000 | 000000 0 |
GP2U FAQs
-
When was GP2U founded?
GP2U was founded in 2011.
-
Who is the founder of GP2U?
James Freeman is the founder of GP2U.
-
Where is GP2U headquartered?
GP2U is headquartered in Hobart, Australia.
-
What is the size of GP2U?
GP2U has 12 total employees.
-
What industry is GP2U in?
GP2U’s primary industry is Other Healthcare Technology Systems.
-
Is GP2U a private or public company?
GP2U is a Private company.
-
What is the current valuation of GP2U?
The current valuation of GP2U is 00.000.
-
What is GP2U’s current revenue?
The current revenue for GP2U is 00000.
-
How much funding has GP2U raised over time?
GP2U has raised $3.2M.
-
Who are GP2U’s investors?
Andrew Pascoe, Hospitals Contribution Fund of Australia, Max Reed, and Sonic Healthcare have invested in GP2U.
-
Who are GP2U’s competitors?
Eucalyptus, Koa Health, Medifi, Doxy.me, and Healee are competitors of GP2U.
-
When was GP2U acquired?
GP2U was acquired on 04-Jun-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »